广发中证创新药产业ETF(515120)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
513,455,977.31 |
-632,815,179.50 |
-1,019,455,569.03 |
-440,293,446.70 |
| 利息合计 |
37,036.99 |
1,968,248.24 |
1,755,084.35 |
5,242,636.88 |
| 其中：存款利息收入 |
37,036.99 |
90,700.51 |
41,451.33 |
113,799.19 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-13,955,472.22 |
-670,818,342.75 |
-472,260,710.73 |
-236,644,138.24 |
| 其中：股票投资收益 |
-43,809,877.69 |
-717,291,038.64 |
-499,122,200.29 |
-271,592,874.06 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
29,854,405.47 |
46,472,695.89 |
26,861,489.56 |
34,948,735.82 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
525,541,686.24 |
34,202,896.00 |
-551,543,851.42 |
-215,870,829.02 |
| 其他收入 |
1,832,726.30 |
1,832,019.01 |
2,593,908.77 |
6,978,883.68 |
| 费用 |
11,282,548.06 |
20,404,860.24 |
10,181,396.77 |
20,588,566.41 |
| 管理人报酬 |
9,052,373.04 |
15,891,599.75 |
7,928,752.88 |
16,022,048.82 |
| 基金托管费 |
1,810,474.61 |
3,178,319.89 |
1,585,750.54 |
3,204,409.71 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
419,700.41 |
1,328,180.56 |
660,723.42 |
1,343,642.48 |
| 利润总额 |
502,173,429.25 |
-653,220,039.74 |
-1,029,636,965.80 |
-460,882,013.11 |
微信公众号
证券之星APP
基本资料
